<DOC>
	<DOC>NCT01796899</DOC>
	<brief_summary>To investigate the bioavailability/bioequivalence of Brivaracetam oral tablets (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam intravenous injection (100 mg) in healthy volunteers.</brief_summary>
	<brief_title>Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Subject is a healthy male or female volunteer aged 1855 years inclusive Subject has a Body Mass Index (BMI) of 18.0 30.0 kg/m^2 and a weight of at least 50 kg (males) or 45 kg (females) Subject has normal vital signs values, Electrocardiograms (ECGs) and clinical laboratory values Female subjects should have a negative pregnancy test or be of nonchildbearing potential Volunteer has participated or is participating in any other clinical studies of investigational drug or another Investigational Medicinal Product (IMP) within the last 3 months Volunteer is not healthy (eg, taking any drug treatments, excessive amount of alcohol, cigarettes or caffeine, having any medical or emotional/psychological problems, a drug/alcohol abuse, having abnormal safety parameters) Subject has an intolerance or allergy against the compound or related drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Brivaracetam</keyword>
</DOC>